# Treatment Study for Children and Adolescents With Acute Promyelocitic Leukemia

> **NCT01226303** · PHASE3 · UNKNOWN · sponsor: **Associazione Italiana Ematologia Oncologia Pediatrica** · enrollment: 300 (estimated)

## Conditions studied

- Acute Promyelocytic Leukemia

## Interventions

- **DRUG:** ATRA
- **DRUG:** ATRA + IDA

## Key facts

- **NCT ID:** NCT01226303
- **Lead sponsor:** Associazione Italiana Ematologia Oncologia Pediatrica
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-01
- **Primary completion:** 2017-06
- **Final completion:** 2018-12
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2017-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01226303

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01226303, "Treatment Study for Children and Adolescents With Acute Promyelocitic Leukemia". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT01226303. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*